Gero logo

Gero

Recent Finacing

Series A

Recent Raise

$6M


Gero is a biotechnology company that uses AI and real-world human health data to decode the relationship between aging and diseases, with the goal of developing therapeutics to combat age-related diseases.

Total Funding

$6M

Headquarters

Palo Alto, USA

Founded

N/A

Website

Focus Areas

aging
chronic diseases
biotechnology

Investors

VitaDAO logo
Melnichek Investments logo